Dynavax Technologies Corporation
Prices are adjusted according to historical splits.
Vitals
- Today's Low:
- $11.2600
- Today's High:
- $11.8000
- Open Price:
- $11.5400
- 52W Low:
- $7.26
- 52W High:
- $18.63
- Prev. Close:
- $11.6200
- Volume:
- 1815669
Company Statistics
- Market Cap.:
- $1.425 billion
- Book Value:
- 3.344
- Revenue TTM:
- $0.673 billion
- Operating Margin TTM:
- 39.1%
- Gross Profit TTM:
- $0.235 billion
- Gross Profit TTM:
- $0.235 billion
- Profit Margin:
- 34.6%
- Return on Assets TTM:
- 19.7%
- Return on Equity TTM:
- 92%
Company Profile
Dynavax Technologies Corporation had its IPO on 2004-02-19 under the ticker symbol DVAX.
The company operates in the LIFE SCIENCES sector and PHARMACEUTICAL PREPARATIONS industry. Dynavax Technologies Corporation has a staff strength of 0 employees.
Stock update
Shares of Dynavax Technologies Corporation opened at $11.54 at the start of the last trading session i.e. 2022-11-02.
The stocks traded within a range of $11.26 - $11.8, and closed at $11.27.
This is a -3.01% slip from the previous day's closing price.
A total volume of 1,815,669 shares were traded at the close of the day’s session.
In the last one week, shares of Dynavax Technologies Corporation have increased by +2.45%.
Dynavax Technologies Corporation's Key Ratios
Dynavax Technologies Corporation has a market cap of $1.425 billion, indicating a price to book ratio of 3.509 and a price to sales ratio of 2.119.
In the last 12-months Dynavax Technologies Corporation’s revenue was $0.673 billion with a gross profit of $0.235 billion and an EBITDA of $0.267 billion. The EBITDA ratio measures Dynavax Technologies Corporation's overall financial performance and is widely used to measure its profitability.
In the trailing 12-month period, Dynavax Technologies Corporation’s operating margin was 39.1% while its return on assets stood at 19.7% with a return of equity of 92%.
In Q2, Dynavax Technologies Corporation’s quarterly earnings growth was a positive 4945% while revenue growth was a positive 386%.
Dynavax Technologies Corporation’s PE and PEG Ratio
- Forward PE
- 6.36
- Trailing PE
- 6.91
- PEG
- 0
Its diluted EPS in the last 12-months stands at $1.63 per share while it has a forward price to earnings multiple of 6.36 and a PEG multiple of 0. A low price to earnings ratio can mean the stock is attractively valued while a high ratio suggests the stock may be overvalued.
The PEG on the other hand provides a broader view compared to the P/E ratio and gives greater insight into Dynavax Technologies Corporation’s profitability.
Dynavax Technologies Corporation stock is trading at a EV to sales ratio of 1.815 and a EV to EBITDA ratio of 4.932. Its price to sales ratio in the trailing 12-months stood at 2.119.
Dynavax Technologies Corporation stock pays annual dividends of $0 per share, indicating a yield of 0% and a payout ratio of 0%.
Balance sheet and cash flow metrics
- Total Assets
- $0.000 billion
- Total Liabilities
- $0.000 billion
- Operating Cash Flow
- $0.000 billion
- Capital Expenditure
- $0.000 billion
- Dividend Payout Ratio
- 0%
Dynavax Technologies Corporation ended 1970 with $0.000 billion in total assets and $131.2 billion in total liabilities. Its intangible assets were valued at $0.000 billion while shareholder equity stood at $0.000 billion.
Dynavax Technologies Corporation ended 1970 with $0.000 billion in deferred long-term liabilities, $0.000 billion in other current liabilities, billion in common stock, $0.000 billion in retained earnings and $0.000 billion in goodwill. Its cash balance stood at $0.000 billion and cash and short-term investments were $0.000 billion. The company’s total short-term debt was $0.000 billion while long-term debt stood at $0.000 billion.
Dynavax Technologies Corporation’s total current assets stands at $0.000 billion while long-term investments were $0.000 billion and short-term investments were $0.000 million. Its net receivables were $0.000 billion compared to accounts payable of $0.000 billion and inventory worth $0.000 billion.
In 1970, Dynavax Technologies Corporation's operating cash flow was $0.000 billion while its capital expenditure stood at $0.000 billion.
Comparatively, Dynavax Technologies Corporation paid $0 billion in dividends in 1970.
Other key metrics
- Current Trading Price
- $11.27
- 52-Week High
- $18.63
- 52-Week Low
- $7.26
- Analyst Target Price
- $24.8
Dynavax Technologies Corporation stock is currently trading at $11.27 per share. It touched a 52-week high of $18.63 and a 52-week low of $18.63. Analysts tracking the stock have a 12-month average target price of $24.8.
Its 50-day moving average was $0 and 200-day moving average was $0 The short ratio stood at indicating a short percent outstanding of 0%.
Around 0% of the company’s stock are held by insiders while 0% are held by institutions.
Frequently Asked Questions About Dynavax Technologies Corporation
Similar Industry Stocks (PHARMACEUTICAL PREPARATIONS)
Most Active
Top Gainers
Top Losers
About
Dynavax Technologies Corporation, a biopharmaceutical company, focuses on developing and commercializing novel vaccines in the United States. The company is headquartered in Emeryville, California.